Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Mass Cytometry Identifies T Cell Populations Associated with Severe Hepatotoxicity in CLL Patients on Upfront Idelalisib

Alexander R. Vartanov, MD, Tiago R Matos, MD, Emily M. McWilliams, PhD, Deepti Gadi, PhD, Deepak Rao, MD PhD, Siddha Kasar, PhD, Benjamin L. Lampson, MD PhD, Stacey M. Fernandes, BS, Jerome Ritz, MD PhD, Jennifer R. Brown, MD PhD

Blood (2018) 132 (Supplement 1): 4413.

https://doi.org/10.1182/blood-2018-99-118734

Published: 2018

Journal Articles

A Phase I/II Study on the Anti-CD3/CD7 Immunotoxin Combination (T-GuardTM) for the Treatment of Steroid-Refractory Acute Gvhd

Christoph Groth, MD, Lenneke F J Groningen, Manita E J Bremmers, Frank W M B Preijers, Harry Dolstra, Tiago R Matos, Christian Reicherts, Eric G van Hooren, Ypke V J M van Oosterhout, John E Levine, MD, James L Ferrara, Nicole M A Blijlevens, Matthias Stelljes, MD, Walter J F M van der Velden

Blood (2017) 130 (Supplement 1): 513.

https://doi.org/10.1182/blood.V130.Suppl_1.513.513

Published: 2017

Journal Articles

Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity

Benjamin L. Lampson, Siddha N. Kasar, Tiago R. Matos, Elizabeth A. Morgan, Laura Rassenti, Matthew S. Davids, David C. Fisher, Arnold S. Freedman, Caron A. Jacobson, Philippe Armand, Jeremy S. Abramson, Jon E. Arnason, Thomas J. Kipps, Joshua Fein, Stacey Fernandes, John Hanna, Jerome Ritz, Haesook T. Kim, Jennifer R. Brown

Blood (2016) 128 (2): 195–203.

https://doi.org/10.1182/blood-2016-03-707133

Published: 2016

Includes: Supplemental data

Journal Articles

Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD

Ana C. Alho, Haesook T. Kim, Marie J. Chammas, Carol G. Reynolds, Tiago R. Matos, Edouard Forcade, Jennifer Whangbo, Sarah Nikiforow, Corey S. Cutler, John Koreth, Vincent T. Ho, Philippe Armand, Joseph H. Antin, Edwin P. Alyea, Joao F. Lacerda, Robert J. Soiffer, Jerome Ritz

Blood (2016) 127 (5): 646–657.

https://doi.org/10.1182/blood-2015-10-672345

Published: 2016

Includes: Supplemental data

Journal Articles

Maturation and Phenotypic Diversity of Human CD4 + Regulatory T Cells in Umbilical Cord Blood and Peripheral Blood from Healthy Donors

Tiago R Matos, MD MSc, Hongye Liu, Masahiro Hirakawa, MD PhD, Ana Cristina Alho, MD, Jerome Ritz, MD

Blood (2015) 126 (23): 2357.

https://doi.org/10.1182/blood.V126.23.2357.2357

Published: 2015

Journal Articles

IL-2, IL-7, IL-15 and IL-6 Induce Differential Activation of Naive and Memory T Cell Subsets

Masahiro Hirakawa, MD PhD, Tiago R Matos, MD MSc, Edouard Forcade, MD, Kathy S. Wang, PhD, Eduardo L Espada, MD, Jennifer Whangbo, MD PhD, Carol G Reynolds, PhD, Marie J Chammas, Kazuyuki Murase, MD PhD, Jerome Ritz, MD

Blood (2015) 126 (23): 3425.

https://doi.org/10.1182/blood.V126.23.3425.3425

Published: 2015

Journal Articles

IL-2 Induces Selective Activation of Helios-Positive Regulatory T Cells and CD56 bright NK Cells in Vitro and in Patients with Chronic Gvhd Receiving Low-Dose IL-2 Therapy

Masahiro Hirakawa, MD PhD, Tiago R Matos, MD MSc, John Koreth, MBBS, DPhil, Edouard Forcade, MD, Jennifer Whangbo, MD PhD, Kazuyuki Murase, MD PhD, Hongye Liu, Sarah Nikiforow, MD PhD, Vincent T Ho, MD, Corey S Cutler, MD MPH, Philippe Armand, MD PhD, Edwin P. Alyea, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, Jerome Ritz, MD

Blood (2015) 126 (23): 919.

https://doi.org/10.1182/blood.V126.23.919.919

Published: 2015

Journal Articles

Altered Expression of Functional Proteins in CD4 Regulatory T Cells during Therapy with Idelalisib

Tiago R Matos, MD MSc, Benjamin L Lampson, MD PhD, Masahiro Hirakawa, MD PhD, Siddha Kasar, PhD, Stacey M. Fernandes, Jennifer R. Brown, MD PhD, Jerome Ritz, MD

Blood (2015) 126 (23): 1735.

https://doi.org/10.1182/blood.V126.23.1735.1735

Published: 2015

NARROW

Mass Cytometry Identifies T Cell Populations Associated with Severe Hepatotoxicity in CLL Patients on Upfront Idelalisib

A Phase I/II Study on the Anti-CD3/CD7 Immunotoxin Combination (T-GuardTM) for the Treatment of Steroid-Refractory Acute Gvhd

Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity

Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD

Maturation and Phenotypic Diversity of Human CD4 + Regulatory T Cells in Umbilical Cord Blood and Peripheral Blood from Healthy Donors

IL-2, IL-7, IL-15 and IL-6 Induce Differential Activation of Naive and Memory T Cell Subsets

IL-2 Induces Selective Activation of Helios-Positive Regulatory T Cells and CD56 bright NK Cells in Vitro and in Patients with Chronic Gvhd Receiving Low-Dose IL-2 Therapy

Altered Expression of Functional Proteins in CD4 Regulatory T Cells during Therapy with Idelalisib

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only